Vitrolife Q3 Net Income SEK 124 Million
Oct 22 (Reuters) - Vitrolife Q3 EBITDA margin 31.6%.
- Q3 revenue SEK 884 million
- Q3 EBITDA SEK 279 million
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement